scholarly journals Development of an automated radiotherapy dose accumulation workflow for locally advanced high‐risk prostate cancer – A technical report

2020 ◽  
Author(s):  
Ashley Ong ◽  
Kellie Knight ◽  
Vanessa Panettieri ◽  
Mathew Dimmock ◽  
Jeffrey Kit Loong Tuan ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Locally Advanced ◽  
Dose Accumulation ◽  
High Risk Prostate Cancer ◽  
Technical Report ◽  
Risk Prostate Cancer ◽  
Radiotherapy Dose

ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer

2017 ◽  
Vol 40 (1) ◽  
pp. 1-10 ◽  
Author(s):  
Patrick W. McLaughlin ◽  
Adam L. Liss ◽  
Paul L. Nguyen ◽  
Dean G. Assimos ◽  
Anthony V. D’Amico ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Locally Advanced ◽  
Appropriateness Criteria ◽  
High Risk Prostate Cancer ◽  
Acr Appropriateness Criteria ◽  
Risk Prostate Cancer

scholarly journals Radical Prostatectomy: An Option for High-Risk Prostate Cancer

2012 ◽  
Vol 2012 ◽  
pp. 1-4
Author(s):  
S. Rausch ◽  
C. Schmitt ◽  
T. Kälble
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
High Risk ◽  
Radical Prostatectomy ◽  
Locally Advanced ◽  
Radical Retropubic Prostatectomy ◽  
Cancer Specific Survival ◽  
High Risk Prostate Cancer ◽  
Risk Prostate Cancer

Introduction. High-risk prostate cancer represents a therapeutic challenge. The role of radical prostatectomy (RP) in patients with extreme PSA values is under discussion.Material and Methods. We retrospectively analysed our data of 56 consecutive patients with preoperative PSA ≥ 40 mg/mL undergoing open radical retropubic prostatectomy from 1999 to 2009. Patient survival and time to PSA recurrence were recorded, and the Kaplan-Meier survival analysis was performed. Postoperative quality of life and functional status were investigated using a SF-12 questionnaire and determining the number of pads used per day.Results. Overall 56 patients were available for followup after a median time of 83.84 months. Locally advanced carcinoma was present in 84% while 16% of patients had organ-confined stages. A positive nodal status was observed in 46%. Overall survival was 95% at five and 81% at 10 years. Cancer-specific survival was 100% for five years and 83% for 10 years. Corresponding biochemical recurrence-free survival was low (52% and 11%, resp.). Quality of life and functional outcomes were favourable.Conclusions. In patients with PSA ≥ 40 mg/mL, RP allows long-term control, exact planning of adjuvant treatment, and identification of curable disease.

The importance of surgery in locally advanced “very high risk” prostate cancer

2016 ◽  
Vol 15 (11) ◽  
pp. e1402-e1403
Author(s):  
C. Gingu ◽  
A. Dick ◽  
M. Crasneanu ◽  
S. Ianiotescu ◽  
A. Andresanu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Locally Advanced ◽  
High Risk Prostate Cancer ◽  
Risk Prostate Cancer ◽  
Very High
Sign in / Sign up

Export Citation Format

Share Document